Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)

NCT00442936 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1380

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Telcagepant potassium 150 mg
DRUG: Telcagepant potassium 300 mg
DRUG: Zolmitriptan 5 mg
DRUG: Placebo to telcagepant 150 mg
DRUG: Placebo to tecagepant 300 mg
DRUG: Placebo to zolmitriptan 5 mg
DRUG: Rescue medication

Sponsor

Merck Sharp & Dohme LLC